CR

Cancer Research and Treatment

Cancer Research and Treatment is the official journal of the Korean Cancer Association, the Korean Society of Medical Oncology, and the Korean Association for Lung Cancer. The journal publishes cancer research and related clinical oncology content and provides online access to current issues, accepted articles, ahead-of-print articles, and archived content.

Looking to publish in Cancer Research and Treatment? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 3.8
Quartile Q2
Open Access Type Open
ISSN 1598-2998
eISSN 2005-9256
Invitation Only No
Cost Range USD 600 per article; USD 300 for case report, correspondence, or erratum.

Submission Instructions

Cancer Research and Treatment accepts the following article types. Click on an article type to view submission instructions.

Original Articles

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must be no more than 250 words. Structured. Purpose, Materials and Methods, Results, and Conclusion.
Manuscript Original Articles must be arranged in the order title page, abstract and keywords, text, author contributions, conflicts of interest, acknowledgments if necessary, references, tables, and figure legends, and the text must be organized as Introduction, Materials and Methods, Results, and Discussion. Keywords must be provided below the abstract, author contributions must use the specified contribution categories, conflicts of interest must be stated within the manuscript, funding must be disclosed in the Funding section, and AI use must be disclosed if applicable.
References Fewer than 30 references. Vancouver. References must be cited with Arabic numerals in brackets in the order cited, listed in English, list all authors when six or fewer are named, list the first six authors followed by et al. when there are more than six, use Medline-style journal abbreviations, and include the DOI for online articles without issue or page numbers.
Figures & Tables The total number of tables plus figures must not exceed 10. Figure images must be uploaded as separate image files, and figure legends must be merged and included in the manuscript. Tables must have titles and be numbered in Arabic numerals in citation order, figures must be numbered in Arabic numerals in citation order and cited in the text, table and figure notes must use lowercase superscript letters for annotations, and all drugs and chemicals must be identified precisely.
Reformat to Cancer Research and Treatment using Livewrite Premium

Review Articles

Cover Letter Unsolicited Review Articles must be accompanied by the authors’ curriculum vitae.
Abstract Abstract requirements are not specified.
Manuscript Manuscripts must be arranged in the sequence title page, abstract and keywords, introduction, materials and methods, results, discussion, references, and tables and figure legends. The title page must include the article category, title, authors’ names, affiliations, department and institution information, a running title, and the corresponding author’s full contact details, and keywords should be provided below the abstract.
References References must be fewer than 30. References must be cited in Arabic numerals in brackets in the order cited, listed in English, and journal titles must be abbreviated in Medline style.
Figures & Tables The total number of tables plus figures must not exceed 10. Each figure must be uploaded as a separate image file, and figure legends must be merged and included in the manuscript. Tables must have titles and be numbered in order cited, figures must be numbered in order cited, and non-original figures require permission.
Reformat to Cancer Research and Treatment using Livewrite Premium

Case Reports

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must not exceed 150 words. Unstructured.
Manuscript Manuscripts must be arranged in the sequence title page, abstract and keywords, introduction, materials and methods, results, discussion, references, and tables and figure legends. The title page must include the article category, and all potential conflicts of interest, research or project support and funding, and any AI assistance must be disclosed in the manuscript.
References Case Reports must have no more than 15 references. References must be cited with Arabic numerals in brackets in order of citation, listed in English, and formatted so that all authors are listed when there are six or fewer and the first six authors are followed by et al. when there are more than six.
Figures & Tables Case Reports must have no more than 5 figures, including tables. Each figure must be uploaded as a separate image file, and figure legends must be merged and included in the manuscript. Tables must have titles and be numbered in order of citation, figures must be numbered in order of citation and cited in the text, and all figures and tables together must not exceed 5.
Reformat to Cancer Research and Treatment using Livewrite Premium

Correspondences

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Correspondences must not exceed 400 words. The manuscript must be arranged in the sequence title page, abstract and keywords, introduction, materials and methods, results, discussion, references, and tables and figure legends. The title page must include the article category, and the manuscript must include 3 to 10 keywords or terms, author contributions, and any AI disclosure if applicable.
References Correspondences must have no more than 5 references. References must be cited with Arabic numerals in brackets and listed in the order cited, with all authors listed for six or fewer authors and the first six authors followed by et al. for more than six authors.
Figures & Tables Correspondences must have no more than 1 table or figure. Each figure must be uploaded as a separate image file, and figure legends must be merged and included in the manuscript. Tables must have titles and be numbered in Arabic numerals, figures must be numbered in Arabic numerals and cited in the text, and the total number of tables plus figures must not exceed 10.
Reformat to Cancer Research and Treatment using Livewrite Premium

Recent Publications

Perceptions and Use of Complementary and Alternative Medicine among Patients with Cancer and Their Family Members (KCSG PC21-19)

Young-Woong Won, Sun Young Rha, Jung Hye Kwon, Yu Jung Kim, Shin Hye Yoo, Myung Ah Lee, Jung Hun Kang, Sun Jin Sym, Young Saing Kim, Sang-Cheol Lee, Myung-Won Lee, Hye Sook Han, Sang-Gon Park, Eun-Kee Song, Jin Young Kim, Seong Hoon Shin, Chi Hoon Maeng, Keun Seok Lee, Hyun Woo Lee, Woo Kyun Bae, Kyu-Hyoung Lim, Yoon Jung Chang, Han Byul Lee, Jung Sun Kim

10.4143/crt.2025.1251
View Publication

Spatial Disparities in Stage-Specific Breast Cancer Incidence and Area-Level Risk Factors in Korea, 2005–2018

Eun Hye Park, Kyu-Won Jung, Seung-sik Hwang, So-Youn Jung, Jae Kwan Jun

10.4143/crt.2025.1268
View Publication

Randomized Phase II Study of Bortezomib, Lenalidomide, and Dexamethasone (VRD) Versus Lenalidomide and Dexamethasone (RD) in Elderly Patients with Newly Diagnosed Multiple Myeloma (KMM1910)

Jun Ho Yi, Sang Eun Yoon, Ji Hyun Lee, Soo Mee Bang, Myung-won Lee, Joon Ho Moon, Je-Jung Lee, Hyeon-Seok Eom, Chang-Ki Min, Young Rok Do, Sungnam Lim, Ho-Jin Shin, Jae Hoon Lee, Hyo Jung Kim, Sung-Soo Yoon, Kihyun Kim

10.4143/crt.2026.0255
View Publication

The Role of Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer with Microsatellite Instability-High or DNA Mismatch Repair Deficiencies: A Multicenter Pooled Analysis (KCSG-CO24-03)

Joon Young Hur, Hana Kim, Soon Il Lee, Se Jun Park, Jina Yun, Seok Yun Kang, Cheolsik Kim, Seung-Hoon Beom, Hyeyeong Kim, So-Yeon Jeon, Jaemin Jo, Yongho Noh, Jong Gwang Kim, Hyun Jin Bang

10.4143/crt.2026.0156
View Publication

Total Body Irradiation, Busulfan, Fludarabine Conditioning for Pediatric Acute Myeloid Leukemia Patients Treated with Hematopoietic Stem Cell Transplantation in Second Complete Remission

Jae Wook Lee, Suejung Jo, Jae Won Yoo, Seongkoo Kim, Nack-Gyun Chung, Bin Cho

10.4143/crt.2026.0086
View Publication

Frequently asked questions

How long does it take to publish?

Initial decision normally within 4 weeks. Revised manuscripts must be resubmitted within 12 weeks of the editorial decision.

Reformat to Cancer Research and Treatment using Livewrite Premium

Is a cover letter required?

A cover letter is expected for non-English manuscripts to confirm professional linguistic revision.

Reformat to Cancer Research and Treatment using Livewrite Premium

What are the publication costs?

Article charges are required for publication. The charge is USD 600 per article, and USD 300 for case report, correspondence, or erratum.

Reformat to Cancer Research and Treatment using Livewrite Premium

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Gastric Cancer Management and Outcomes Breast Cancer Treatment Studies Lung Cancer Research Studies Global Cancer Incidence and Screening Head and Neck Cancer Studies Colorectal Cancer Treatments and Studies Lymphoma Diagnosis and Treatment Cholangiocarcinoma and Gallbladder Cancer Studies Esophageal Cancer Research and Treatment Colorectal Cancer Surgical Treatments Hepatocellular Carcinoma Treatment and Prognosis Cancer Immunotherapy and Biomarkers HER2/EGFR in Cancer Research Multiple and Secondary Primary Cancers Cancer Treatment and Pharmacology Cancer survivorship and care Glioma Diagnosis and Treatment Cancer Genomics and Diagnostics Pancreatic and Hepatic Oncology Research Cancer Risks and Factors Endometrial and Cervical Cancer Treatments Helicobacter pylori-related gastroenterology studies Colorectal Cancer Screening and Detection

Related Journals

JC
JACC CardioOncology Elsevier BV
MT
Molecular Therapy Oncology CELL PRESS
JJ
JNCI Journal of the National Cancer Institute Oxford University Press
Ne
Neoplasia Elsevier BV
Ps
Psycho-Oncology WILEY
CM
Cancer Medicine WILEY